3651 results for «259»
3651 results
TAVI for aortic regurgitation - Addressing an unmet need with the JenaValve Trilogy heart valve system
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the unmet need in treating AR, to discover the performance of the Trilogy System (a new TAVI device for the treatment of AR), as well as to explore the future of TAVI for AR.
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
Your most challenging TAVI cases - Achieving precision and control with Evolut platform
18 May 2022 – From EuroPCR 2022
How to deal with challenging anatomies? Find answers in this EuroPCR 2022 session with case studies to explore and learn how to achieve optimal patient outcomes with Evolut platform, uncover practical tips and techniques to achieve implant precision and control, and become familiar with technical considerations and procedural execution...
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Incorporating coronary orbital atherectomy to my practice
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to examine the improvement of technology in the treatment of highly calcified coronary lesions: get a practical perspective on how to integrate and perform orbital atherectomy in your clinical practice, become aware of its differential aspects compared to other plaque preparation...
Coronary microvascular dysfunction in case examples: invisible, measurable, treatable
18 May 2022 – From EuroPCR 2022
In this very practical session from EuroPCR 2022 focusing on microcirculation, learn how to perform a step-by-step assessment of the coronary microcirculation in the cathlab, discuss the whole management of patients with coronary microvascular dysfunction (CMD), and understand how to use coronary flow reserve (CFR) and index...
Is PCI enough in STEMI?
18 May 2022 – From EuroPCR 2022
With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct...
Nothing to fear - a guide to combine DCB and DES in hybrid PCI
19 May 2022 – From EuroPCR 2022
DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
